NOVO NORDISK INC. for NOVO NORDISK INC.
What was lobbied
7 issue areas, each in the filer's own words, with who lobbied on it and where.
Trade (domestic/foreign) TRD
Trans-Pacific Partnership (TPP): biosimilar provisions
| Lobbyist | Covered position, as disclosed |
|---|---|
| TRICIA BROOKS | — |
| MICHAEL MAWBY | — |
| STEPHEN MCGILL | — |
| CHRISTOPHER MCGOWEN | — |
| MORIAH MERKEL | — |
| SARAH ELIZABETH NORDSTROM | — |
| SHAYLAH NUNN | — |
| LAUREN ELIZABETH SEMENIUK | — |
Taxation/Internal Revenue Code TAX
H.R. 436 Protect Medical Innovation Act of 2011
| Lobbyist | Covered position, as disclosed |
|---|---|
| TRICIA BROOKS | — |
| MICHAEL MAWBY | — |
| STEPHEN MCGILL | — |
| CHRISTOPHER MCGOWEN | — |
| MORIAH MERKEL | — |
| SARAH ELIZABETH NORDSTROM | — |
| SHAYLAH NUNN | — |
| LAUREN ELIZABETH SEMENIUK | — |
Health Issues HCR
P.L. 111-148, Patient Protection and Affordable Care Act of 2009 (ACA) and P.L. 111-152, The Health Care & Education Affordability Reconciliation Act of 2010: biosimilar provisions
| Lobbyist | Covered position, as disclosed |
|---|---|
| TRICIA BROOKS | — |
| MICHAEL MAWBY | — |
| STEPHEN MCGILL | — |
| CHRISTOPHER MCGOWEN | — |
| MORIAH MERKEL | — |
| SARAH ELIZABETH NORDSTROM | — |
| SHAYLAH NUNN | — |
| LAUREN ELIZABETH SEMENIUK | — |
Medicare/Medicaid MMM
P.L. 111-148, Patient Protection and Affordable Care Act of 2009 (ACA) and P.L. 111-152, The Health Care & Education Affordability Reconciliation Act of 2010; CMS Proposed Coverage Decision Memorandum for Intensive Behavioral Therapy for Obesity; Medicare Diabetes Screening; HR 2741, Preventing Diabetes in Medicare Act of 2011 and Prediabetes generally; Medicaid coverage of obesity counseling and expanding provider type; Issues related to Medicare Part D and Medicaid rebates as contained in P.L. 112-25 Budget Control Act of 2011 (deficit reduction)
| Lobbyist | Covered position, as disclosed |
|---|---|
| TRICIA BROOKS | — |
| MICHAEL MAWBY | — |
| STEPHEN MCGILL | — |
| CHRISTOPHER MCGOWEN | — |
| MORIAH MERKEL | — |
| SARAH ELIZABETH NORDSTROM | — |
| SHAYLAH NUNN | — |
| LAUREN ELIZABETH SEMENIUK | — |
Budget/Appropriations BUD
S. 3295 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act FY2013 (National Diabetes Prevention Program); Issues related to modernizing cost estimates with respect to preventive health legislation (scoring) and National Diabetes Prevention Program
| Lobbyist | Covered position, as disclosed |
|---|---|
| TRICIA BROOKS | — |
| MICHAEL MAWBY | — |
| STEPHEN MCGILL | — |
| CHRISTOPHER MCGOWEN | — |
| MORIAH MERKEL | — |
| SARAH ELIZABETH NORDSTROM | — |
| SHAYLAH NUNN | — |
| LAUREN ELIZABETH SEMENIUK | — |
Law Enforcement/Crime/Criminal Justice LAW
S. 1002 SAFE DOSES Act and HR 4223 Safe Doses Act (Modernizing criminal laws concerning theft of medical products)
| Lobbyist | Covered position, as disclosed |
|---|---|
| TRICIA BROOKS | — |
| MICHAEL MAWBY | — |
| STEPHEN MCGILL | — |
| CHRISTOPHER MCGOWEN | — |
| MORIAH MERKEL | — |
| SARAH ELIZABETH NORDSTROM | — |
| SHAYLAH NUNN | — |
| LAUREN ELIZABETH SEMENIUK | — |
Pharmacy PHA
P.L. 111-148, Patient Protection and Affordable Care Act of 2009 (ACA) and P.L. 111-152, The Health Care & Education Affordability Reconciliation Act of 2010: Issues regarding comparative effectiveness, implementation of Physician Payment Sunshine provisions and Prescription Drug Sample reporting provisions; S.3187 FDA Safety and Innovation Act (PDUFA V); H.R. 4274 Best Pharmaceuticals for Children Act/Pediatric Research Exclusivity Act; H.R. 3026 Safeguarding America's Pharmaceuticals Act of 2011; Pharmaceutical Traceability Enhancement Code (Rx TEC) Act; H.R. 5973 FY2013 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act (FDA funding); 340B
| Lobbyist | Covered position, as disclosed |
|---|---|
| TRICIA BROOKS | — |
| MICHAEL MAWBY | — |
| STEPHEN MCGILL | — |
| CHRISTOPHER MCGOWEN | — |
| MORIAH MERKEL | — |
| SARAH ELIZABETH NORDSTROM | — |
| SHAYLAH NUNN | — |
| LAUREN ELIZABETH SEMENIUK | — |
Foreign entities
Foreign owners and affiliates the filer disclosed. Amounts are as declared on this filing.
| Entity | Country | Principal place of business | Ownership | Contribution declared |
|---|---|---|---|---|
| NOVO A/S | Denmark | Denmark | 25.5% | — |
| NOVO NORDISK FONDEN (FOUNDATION) | Denmark | Denmark | 25.5% | — |
| NOVO NORDISK A/S | Denmark | Denmark | 100.0% | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.